Previous 10 | Next 10 |
After last week's record inflation read-out at 5%, well-respected hedge fund manager PT Jones shared his opinion at a CNBC interview on why it won't be transitory. In this article, I discuss the three main drivers for inflation. The data shows that they remain at unprecedented levels,...
Stocks moved another leg higher in May. I am continuing my monthly investment plans while awaiting a market correction or possibly a real crash once market euphoria has come down. My dividend income amounted to $480, up 37% sequentially and 35% year over year. Gifted Working T...
I am long-term bullish on American innovation and the biotech sector. The SPDR S&P Biotech ETF is a great choice with its focus on smaller biotech companies, its equal weight indexing approach, and its diversification. Other additional considerations include its relatively low...
AbbVie (ABBV) announces new data from the Phase 3 GLOW study comparing the efficacy and safety of the combination of Johnson & Johnson (JNJ) company Janssen Biotech's Imbruvica (ibrutinib) plus Venclexta/Venclyxto (venetoclax) (I+V) vs. chlorambucil plus obinutuzumab (C+O) for ...
The iShares Preferred and Income Securities ETF (PFF) offers a convenient choice to invest in preferred stocks with low cost and strong block liquidity. This post provides a closer look under the hood to better understand its pros and cons, especially the aspects of alpha generation b...
Shanghai CARsgen Therapeutics is staging an IPO on the Hong Kong Exchange that could raise $400 million to support development of the company's CAR-T portfolio. Beijing's BeiGene presented positive interim results from Phase III trial that compared its BTK candidate to AbbVie's Imbruv...
Are These The Best Health Care Stocks To Buy This Week? As the world continues to deal with the global coronavirus pandemic, investors could still be eyeing health care stocks . While they may not be the most active stocks in the stock market today , health care stocks would...
IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Shows Superior Progression-Free Survival Compared to Chlorambucil Plus Obinutuzumab in First-line Chronic Lymphocytic Leukemia (CLL) Phase 3 GLOW Study - All-oral, once-daily, chemotherapy-...
U.S. Bancorp (USB), the fifth-largest commercial bank in the US, is a very well-run bank with superior efficiency and profitability compared to its peers. USB is an excellent defensive candidate, with long term return supported both by a sustainable dividend yield currently near 2.8% ...
Investing In Cannabis Stocks Long Term In June Are you looking for ways to invest in marijuana stocks for the long term? In 2021 top cannabis stocks offer investors exposure to one of the fastest-growing markets in the world. In the next five years, cannabis sales are predicted to m...
News, Short Squeeze, Breakout and More Instantly...
2024-04-29 11:00:06 ET Evan Seigerman from BMO Capital issued a price target of $180.00 for ABBV on 2024-04-29 09:49:00. The adjusted price target was set to $180.00. At the time of the announcement, ABBV was trading at $158.5841. The overall price target consensus is at...
Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...
2024-04-28 04:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...